{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:41:38Z","timestamp":1795034498889,"version":"4.10.2"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"crossref","award":["995714"],"award-info":[{"award-number":["995714"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>5-Fluorouracil (5-FU) is one of the most common chemotherapeutic agents used in treating solid tumors, and the 5-FU-induced cardiotoxicity is the second cause of cardiotoxicity induced by chemotherapeutic drugs. Propolis (Pro) has vigorous anti-inflammatory activity. Its cardio-protective characteristic against doxorubicin-induced cardiotoxicity was previously proven. The current study aimed to appraise the effect of Pro on 5-FU-induced cardiotoxicity in rats. Twenty-four male Wistar rats were divided into four groups: Control, 5-FU, 5-FU\u2009+\u2009Pro 250\u00a0mg\/kg, and 5-FU\u2009+\u2009Colchicine (CLC) 5\u00a0mg\/kg. Different hematological, serological, biochemical, histopathological, and molecular assays were performed to assess the study\u2019s aim. Moreover, a rat myocardium (H9C2(2\u20131)) cell line was also used to assess this protective effect in-vitro. 5-FU resulted in significant cardiotoxicity represented by an increase in malondialdehyde (MDA) levels, cyclooxygenase-2 (COX-2) and tumor necrosis factor-\u03b1 (TNF-\u03b1) expression, cardiac enzyme levels, and histopathological degenerations. 5-FU treatment also decreased bodyweight, total anti-oxidant capacity (TAC), catalase (CAT) levels, blood cell counts, and hemoglobin (Hb) levels. In addition, 5-FU disrupted ECG parameters, including increased elevation in the ST-segment and increased QRS complex and QTc duration. Treating with Pro reduced oxidative stress, cardiac enzymes, histopathological degenerations, and COX-2 expression in cardiac tissue alleviated ECG disturbances and increased the number of blood cells and TAC levels. Moreover, 5-FU-induced bodyweight loss was ameliorated after treatment with Pro. Our results demonstrated that treatment with Pro significantly improved cardiotoxicity induced by 5-FU in rats.<\/jats:p>","DOI":"10.1038\/s41598-022-12735-y","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T15:05:05Z","timestamp":1653318305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The effect of propolis on 5-fluorouracil-induced cardiac toxicity in rats"],"prefix":"10.1038","volume":"12","author":[{"given":"Mohammad","family":"Barary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezvan","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohrab","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson J.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Mansoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence T.","family":"Sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Moghadamnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"12735_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","volume":"70","author":"GA Roth","year":"2017","unstructured":"Roth, G. A. et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J. Am. Coll. Cardiol. 70, 1\u201325 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12735_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685\u20131695 (2005).","journal-title":"N. Engl. J. Med."},{"key":"12735_CR3","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.2459\/JCM.0000000000000377","volume":"17","author":"N Maurea","year":"2016","unstructured":"Maurea, N. et al. Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors. J. Cardiovasc. Med. 17, e19\u2013e26 (2016).","journal-title":"J. Cardiovasc. Med."},{"key":"12735_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/02841860903524396","volume":"49","author":"V Ranpura","year":"2010","unstructured":"Ranpura, V., Hapani, S., Chuang, J. & Wu, S. Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials. Acta Oncol. 49, 287\u2013297 (2010).","journal-title":"Acta Oncol."},{"key":"12735_CR5","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.1200\/JCO.2007.15.6331","volume":"26","author":"M Schmidinger","year":"2008","unstructured":"Schmidinger, M. et al. Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma. J. Clin. Oncol. 26, 5204\u20135212 (2008).","journal-title":"J. Clin. Oncol."},{"key":"12735_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tox.2017.03.006","volume":"382","author":"TP Chambers","year":"2017","unstructured":"Chambers, T. P., Santiesteban, L., Gomez, D. & Chambers, J. W. Sab mediates mitochondrial dysfunction involved in imatinib mesylate-induced cardiotoxicity. Toxicology 382, 24\u201335 (2017).","journal-title":"Toxicology"},{"key":"12735_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.toxlet.2018.08.003","volume":"296","author":"Z Xu","year":"2018","unstructured":"Xu, Z. et al. High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity. Toxicol. Lett. 296, 39\u201347 (2018).","journal-title":"Toxicol. Lett."},{"key":"12735_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40959-016-0012-4","volume":"2","author":"A de Angelis","year":"2016","unstructured":"de Angelis, A. et al. Doxorubicin cardiotoxicity and target cells: A broader perspective. Cardio-Oncol. 2, 2 (2016).","journal-title":"Cardio-Oncol."},{"key":"12735_CR9","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","volume":"39","author":"A Polk","year":"2013","unstructured":"Polk, A., Vaage-Nilsen, M., Vistisen, K. & Nielsen, D. L. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors. Cancer Treat. Rev. 39, 974\u2013984 (2013).","journal-title":"Cancer Treat. Rev."},{"key":"12735_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0163-7258(90)90056-8","volume":"48","author":"WB Parker","year":"1990","unstructured":"Parker, W. B. & Cheng, Y. C. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther. 48, 381\u2013395 (1990).","journal-title":"Pharmacol. Ther."},{"key":"12735_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/179663a0","volume":"179","author":"C Heidelberger","year":"1957","unstructured":"Heidelberger, C. et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179, 663\u2013666 (1957).","journal-title":"Nature"},{"key":"12735_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/2050-6511-15-47","volume":"15","author":"A Polk","year":"2014","unstructured":"Polk, A., Vistisen, K., Vaage-Nilsen, M. & Nielsen, D. L. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity. BMC Pharmacol. Toxicol. 15, 47 (2014).","journal-title":"BMC Pharmacol. Toxicol."},{"key":"12735_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00432-007-0250-9","volume":"134","author":"C Kosmas","year":"2008","unstructured":"Kosmas, C. et al. Cardiotoxicity of fluoropyrimidines in different schedules of administration: A prospective study. J. Cancer Res. Clin. Oncol. 134, 75\u201382 (2008).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"12735_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0021-5198(19)52945-6","volume":"30","author":"I Matsubara","year":"1980","unstructured":"Matsubara, I., Kamiya, J. & Imai, S. Cardiotoxic effects of 5-fluorouracil in the guinea pig. Jpn. J. Pharmacol. 30, 871\u2013879 (1980).","journal-title":"Jpn. J. Pharmacol."},{"key":"12735_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0140-6736(77)90339-7","volume":"2","author":"DL Stevenson","year":"1977","unstructured":"Stevenson, D. L., Mikhailidis, D. P. & Gillett, D. S. Cardiotoxicity of 5-fluorouracil. Lancet 2, 406\u2013407 (1977).","journal-title":"Lancet"},{"key":"12735_CR16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/oxfordjournals.annonc.a010723","volume":"7","author":"M Cwikiel","year":"1996","unstructured":"Cwikiel, M., Eskilsson, J., Albertsson, M. & Stavenow, L. The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in the culture. Ann. Oncol. 7, 731\u2013737 (1996).","journal-title":"Ann. Oncol."},{"key":"12735_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2016.01.002","volume":"32","author":"J Gu","year":"2016","unstructured":"Gu, J. et al. Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity. Int. Immunopharmacol. 32, 1\u20137 (2016).","journal-title":"Int. Immunopharmacol."},{"key":"12735_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.etap.2013.05.006","volume":"36","author":"AI Matouk","year":"2013","unstructured":"Matouk, A. I., Taye, A., Heeba, G. H. & El-Moselhy, M. A. Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats. Environ. Toxicol. Pharmacol. 36, 443\u2013450 (2013).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"12735_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-3835(95)04021-8","volume":"99","author":"O Kozluca","year":"1996","unstructured":"Kozluca, O. et al. Prevention of doxorubicin induced cardiotoxicity by catechin. Cancer Lett. 99, 1\u20136 (1996).","journal-title":"Cancer Lett."},{"key":"12735_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-9880.1000337","volume":"5","author":"M Katamura","year":"2014","unstructured":"Katamura, M. Curcumin attenuates doxorubicin-induced cardiotoxicity by inducing autophagy via the regulation of JNK phosphorylation. J. Clin. Exp. Cardiol. 5, 2 (2014).","journal-title":"J. Clin. Exp. Cardiol."},{"key":"12735_CR21","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1111\/febs.12969","volume":"281","author":"P Aryal","year":"2014","unstructured":"Aryal, P. et al. Baicalein induces autophagic cell death through AMPK\/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells. FEBS J. 281, 4644\u20134658 (2014).","journal-title":"FEBS J."},{"key":"12735_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11010-014-1974-x","volume":"390","author":"RF Prietsch","year":"2014","unstructured":"Prietsch, R. F. et al. Genistein induces apoptosis and autophagy in human breast MCF-7 cells by modulating the expression of proapoptotic factors and oxidative stress enzymes. Mol. Cell. Biochem. 390, 235\u2013242 (2014).","journal-title":"Mol. Cell. Biochem."},{"key":"12735_CR23","first-page":"1","volume":"2017","author":"W Yu","year":"2017","unstructured":"Yu, W. et al. Apigenin attenuates adriamycin-induced cardiomyocyte apoptosis via the PI3K\/AKT\/mTOR pathway. Evid.-Based Complement. Alternat. Med. 2017, 1\u20139 (2017).","journal-title":"Evid.-Based Complement. Alternat. Med."},{"key":"12735_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/exmp.1995.1021","volume":"62","author":"S Chopra","year":"1995","unstructured":"Chopra, S., Pillai, K. K., Husain, S. Z. & Girl, D. K. Propolis protects against doxorubicin-induced myocardiopathy in rats. Exp. Mol. Pathol. 62, 190\u2013198 (1995).","journal-title":"Exp. Mol. Pathol."},{"key":"12735_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/DER.0000000000000011","volume":"24","author":"AC de Groot","year":"2013","unstructured":"de Groot, A. C. Propolis: A review of properties, applications, chemical composition, contact allergy, and other adverse effects. Dermatitis 24, 263\u2013282 (2013).","journal-title":"Dermatitis"},{"key":"12735_CR26","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/j.2042-7158.2011.01331.x","volume":"63","author":"MAE Watanabe","year":"2011","unstructured":"Watanabe, M. A. E., Amarante, M. K., Conti, B. J. & Sforcin, J. M. Cytotoxic constituents of propolis inducing anticancer effects: A review. J. Pharm. Pharmacol. 63, 1378\u20131386 (2011).","journal-title":"J. Pharm. Pharmacol."},{"key":"12735_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/ecam\/nem147","volume":"6","author":"MC B\u00fafalo","year":"2009","unstructured":"B\u00fafalo, M. C., Candeias, J. M. G. & Sforcin, J. M. In vitro cytotoxic effect of Brazilian green propolis on human laryngeal epidermoid carcinoma (HEp-2) Cells. Evid.-Based Complement. Alternat. Med. 6, 483\u2013487 (2009).","journal-title":"Evid.-Based Complement. Alternat. Med."},{"key":"12735_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12016-012-8322-2","volume":"44","author":"GC-F Chan","year":"2013","unstructured":"Chan, G.C.-F., Cheung, K.-W. & Sze, D.M.-Y. The immunomodulatory and anticancer properties of propolis. Clin. Rev. Allergy Immunol. 44, 262\u2013273 (2013).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"12735_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1590\/S1517-83822006000200002","volume":"37","author":"RDO Orsi","year":"2006","unstructured":"Orsi, R. D. O., Sforcin, J. M., Funari, S. R. C., Fernandes Junior, A. & Bankova, V. Synergistic effect of propolis and antibiotics on the Salmonella Typhi. Braz. J. Microbiol. 37, 108\u2013112 (2006).","journal-title":"Braz. J. Microbiol."},{"key":"12735_CR30","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1111\/j.1365-2672.2009.04354.x","volume":"107","author":"MC B\u00fafalo","year":"2009","unstructured":"B\u00fafalo, M. C. et al. Anti-poliovirus activity of Baccharis dracunculifolia and propolis by cell viability determination and real-time PCR. J. Appl. Microbiol. 107, 1669\u20131680 (2009).","journal-title":"J. Appl. Microbiol."},{"key":"12735_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1590\/S0104-79302001000100009","volume":"7","author":"JM Sforcin","year":"2001","unstructured":"Sforcin, J. M., Fernandes J\u00fanior, A., Lopes, C. A. M., Funari, S. R. C. & Bankova, V. Seasonal effect of Brazilian propolis on Candida albicans and Candida tropicalis. J. Venom. Anim. Toxins 7, 139\u2013144 (2001).","journal-title":"J. Venom. Anim. Toxins"},{"key":"12735_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.phymed.2004.07.008","volume":"13","author":"SF Freitas","year":"2006","unstructured":"Freitas, S. F., Shinohara, L., Sforcin, J. M. & Guimar\u00e3es, S. In vitro effects of propolis on Giardia duodenalis trophozoites. Phytomedicine 13, 170\u2013175 (2006).","journal-title":"Phytomedicine"},{"key":"12735_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cryobiol.2019.04.003","volume":"88","author":"A Braik","year":"2019","unstructured":"Braik, A., Lahouel, M., Merabet, R., Djebar, M. R. & Morin, D. Myocardial protection by propolis during prolonged hypothermic preservation. Cryobiology 88, 29\u201337 (2019).","journal-title":"Cryobiology"},{"key":"12735_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/07391102.2017.1288660","volume":"36","author":"R Ekhteiari Salmas","year":"2018","unstructured":"Ekhteiari Salmas, R. et al. The effects of pollen, propolis, and caffeic acid phenethyl ester on tyrosine hydroxylase activity and total RNA levels in hypertensive rats caused by nitric oxide synthase inhibition: Experimental, docking and molecular dynamic studies. J. Biomol. Struct. Dyn. 36, 609\u2013620 (2018).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"12735_CR35","first-page":"50","volume":"22","author":"H Afrouzan","year":"2018","unstructured":"Afrouzan, H., Tahghighi, A., Zakeri, S. & Es-Haghi, A. Chemical composition and antimicrobial activities of Iranian propolis. Iran Biomed. J. 22, 50\u201365 (2018).","journal-title":"Iran Biomed. J."},{"key":"12735_CR36","first-page":"50","volume":"22","author":"H Afrouzan","year":"2018","unstructured":"Afrouzan, H., Tahghighi, A., Zakeri, S. & Es-Haghi, A. Chemical composition and antimicrobial activities of Iranian Propolis. Iran. Biomed. J. 22, 50\u201365 (2018).","journal-title":"Iran. Biomed. J."},{"key":"12735_CR37","first-page":"191","volume":"11","author":"F Asgharpour","year":"2020","unstructured":"Asgharpour, F., Moghadamnia, A. A., Kazemi, S., Nouri, H. R. & Motallebnejad, M. Applying GC-MS analysis to identify chemical composition of Iranian propolis prepared with different solvent and evaluation of its biological activity. Caspian J. Intern. Med. 11, 191\u2013198 (2020).","journal-title":"Caspian J. Intern. Med."},{"key":"12735_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/and.14063","volume":"53","author":"M Pirzadeh","year":"2021","unstructured":"Pirzadeh, M., Barary, M., Hosseini, S. M., Kazemi, S. & Moghadamnia, A. A. Ameliorative effect of Alpinia officinarum Hance extract on nonylphenol-induced reproductive toxicity in male rats. Andrologia 53, 2 (2021).","journal-title":"Andrologia"},{"key":"12735_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejphar.2010.06.065","volume":"644","author":"V Patel","year":"2010","unstructured":"Patel, V., Upaganlawar, A., Zalawadia, R. & Balaraman, R. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: A biochemical, electrocardiographic and histoarchitectural evaluation. Eur. J. Pharmacol. 644, 160\u2013168 (2010).","journal-title":"Eur. J. Pharmacol."},{"key":"12735_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1042\/cs0840407","volume":"84","author":"NJ Miller","year":"1993","unstructured":"Miller, N. J., Rice-Evans, C., Davies, M. J., Gopinathan, V. & Milner, A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 84, 407\u2013412 (1993).","journal-title":"Clin. Sci."},{"key":"12735_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000347136","volume":"161","author":"HR Nouri","year":"2013","unstructured":"Nouri, H. R., Sankian, M., Afsharzadeh, D. & Varasteh, A. Immunotherapy with a recombinant hybrid molecule alleviates allergic responses more efficiently than an allergenic cocktail or pollen extract in a model of Chenopodium album allergy. Int. Arch. Allergy Immunol. 161, 325\u2013332 (2013).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"12735_CR42","doi-asserted-by":"publisher","first-page":"45e","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, 45e\u2013445 (2001).","journal-title":"Nucleic Acids Res."},{"key":"12735_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.lfs.2021.119390","volume":"276","author":"HR Sameni","year":"2021","unstructured":"Sameni, H. R. et al. Co-administration of 5FU and propolis on AOM\/DSS induced colorectal cancer in BALB-c mice. Life Sci. 276, 2 (2021).","journal-title":"Life Sci."},{"key":"12735_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2015.03.033","volume":"363","author":"KA Manu","year":"2015","unstructured":"Manu, K. A. et al. Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-\u03baB signaling cascade in gastric cancer. Cancer Lett. 363, 28\u201336 (2015).","journal-title":"Cancer Lett."},{"key":"12735_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.redox.2021.102144","volume":"47","author":"C Yang","year":"2021","unstructured":"Yang, C. et al. Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells. Redox. Biol. 47, 2 (2021).","journal-title":"Redox. Biol."},{"key":"12735_CR46","doi-asserted-by":"publisher","first-page":"8601","DOI":"10.3390\/molecules16108601","volume":"16","author":"A Ra\u0161kovi\u0107","year":"2011","unstructured":"Ra\u0161kovi\u0107, A. et al. The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules 16, 8601\u20138613 (2011).","journal-title":"Molecules"},{"key":"12735_CR47","doi-asserted-by":"publisher","first-page":"466","DOI":"10.7150\/ijbs.5.466","volume":"5","author":"HI El-Sayyad","year":"2009","unstructured":"El-Sayyad, H. I. et al. Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int. J. Biol. Sci. 5, 466\u2013473 (2009).","journal-title":"Int. J. Biol. Sci."},{"key":"12735_CR48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1034\/j.1399-302X.2003.00075.x","volume":"18","author":"I von B\u00fcltzingsl\u00f6wen","year":"2003","unstructured":"von B\u00fcltzingsl\u00f6wen, I., Adlerberth, I., Wold, A. E., Dahl\u00e9n, G. & Jontell, M. Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol. Immunol. 18, 278\u2013284 (2003).","journal-title":"Oral Microbiol. Immunol."},{"key":"12735_CR49","first-page":"249","volume":"120","author":"H Aygun","year":"2019","unstructured":"Aygun, H. & Gul, S. S. Cardioprotective effect of melatonin and agomelatine on doxorubicin-induced cardiotoxicity in a rat model: An electrocardiographic, scintigraphic and biochemical study. Bratisl. Lek. Listy 120, 249\u2013255 (2019).","journal-title":"Bratisl. Lek. Listy"},{"key":"12735_CR50","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jpn.12056","volume":"98","author":"YA Attia","year":"2014","unstructured":"Attia, Y. A. et al. Growth performance, carcass quality, biochemical and haematological traits and immune response of growing rabbits as affected by different growth promoters. J. Anim. Physiol. Anim. Nutr. (Berl) 98, 128\u2013139 (2014).","journal-title":"J. Anim. Physiol. Anim. Nutr. (Berl)"},{"key":"12735_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3354\/dao02866","volume":"114","author":"ME Yonar","year":"2015","unstructured":"Yonar, M. E., Yonar, S. M., Pala, A., Silici, S. & Sa\u0287lam, N. Trichlorfon-induced haematological and biochemical changes in Cyprinus carpio: Ameliorative effect of propolis. Dis. Aquat. Organ 114, 209\u2013216 (2015).","journal-title":"Dis. Aquat. Organ"},{"key":"12735_CR52","first-page":"1465","volume":"30","author":"N Anghel","year":"2015","unstructured":"Anghel, N. et al. Chrysin attenuates cardiomyocyte apoptosis and loss of intermediate filaments in a mouse model of mitoxantrone cardiotoxicity. Histol. Histopathol. 30, 1465\u20131475 (2015).","journal-title":"Histol. Histopathol."},{"key":"12735_CR53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.intimp.2021.107533","volume":"95","author":"J Gu","year":"2021","unstructured":"Gu, J. et al. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2\/Sirt3 signaling pathway. Int. Immunopharmacol. 95, 2 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"12735_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MCA.0b013e32834e4ef1","volume":"23","author":"DM Lofthus","year":"2012","unstructured":"Lofthus, D. M., Stevens, S. R., Armstrong, P. W., Granger, C. B. & Mahaffey, K. W. Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction. Coron Artery Dis. 23, 22\u201330 (2012).","journal-title":"Coron Artery Dis."},{"key":"12735_CR55","doi-asserted-by":"publisher","DOI":"10.5114\/amsad.2020.103028","volume":"5","author":"DK Djakpo","year":"2020","unstructured":"Djakpo, D. K., Wang, Z. Q. & Shrestha, M. The significance of transaminase ratio (AST\/ALT) in acute myocardial infarction. Arch. Med. Sci. Atheroscl. Dis. 5, e279 (2020).","journal-title":"Arch. Med. Sci. Atheroscl. Dis."},{"key":"12735_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbrc.2021.11.005","volume":"585","author":"M Lotfi","year":"2021","unstructured":"Lotfi, M. et al. The protective effects of quercetin nano-emulsion on intestinal mucositis induced by 5-fluorouracil in mice. Biochem. Biophys. Res. Commun. 585, 75\u201381 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12735_CR57","first-page":"2","volume":"21","author":"M Alyane","year":"2008","unstructured":"Alyane, M., Kebsa, L. B. W., Boussenane, H. N., Rouibah, H. & Lahouel, M. Cardioprotective effects and mechanism of action of polyphenols extracted from propolis against doxorubicin toxicity. Pak. J. Pharmac. Sci. 21, 2 (2008).","journal-title":"Pak. J. Pharmac. Sci."},{"key":"12735_CR58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1155\/2021\/9719906","volume":"2021","author":"H Laaroussi","year":"2021","unstructured":"Laaroussi, H. et al. Protective effect of honey and propolis against gentamicin-induced oxidative stress and hepatorenal damages. Oxid. Med. Cell Longev 2021, 2 (2021).","journal-title":"Oxid. Med. Cell Longev"},{"key":"12735_CR59","first-page":"63","volume":"27","author":"S Kumar","year":"1995","unstructured":"Kumar, S., Gupta, R. K. & Samal, N. 5-fluorouracil induced cardiotoxicity in albino rats. Mater. Med. Pol. 27, 63\u201366 (1995).","journal-title":"Mater. Med. Pol."},{"key":"12735_CR60","doi-asserted-by":"publisher","first-page":"47046","DOI":"10.1007\/s11356-021-13969-5","volume":"28","author":"V Gelen","year":"2021","unstructured":"Gelen, V. et al. The protective effects of hesperidin and curcumin on 5-fluorouracil-induced nephrotoxicity in mice. Environ. Sci. Pollut. Res. Int. 28, 47046\u201347055 (2021).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"12735_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ctim.2020.102380","volume":"50","author":"M Jalali","year":"2020","unstructured":"Jalali, M. et al. Effect of propolis intake on serum C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-\u03b1) levels in adults: A systematic review and meta-analysis of clinical trials. Complement Ther. Med. 50, 2 (2020).","journal-title":"Complement Ther. Med."}],"updated-by":[{"DOI":"10.1038\/s41598-022-17003-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12735-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:54:19Z","timestamp":1669348459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12735-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12735"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12735-y","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-022-17003-7","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-022-17003-7","URL":"https:\/\/doi.org\/10.1038\/s41598-022-17003-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Terence T. Sio reports that he provides strategic and scientific recommendations as a member of the Advisory Board and speaker for Novocure, Inc. and also as a member of the Advisory Board to Galera Therapeutics, which are not in any way associated with the content or disease site as presented in this manuscript.\u00a0All other authors have no relevant financial interests to be declared.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8661"}}